From- Fondazione Per La Ricerca Ospedale Di Bergamo- Ets

This study is testing a new digital app designed to help young people (ages 14-20) who have had or are waiting for a liver transplant. The app helps them manage their health and medications, especially as they move from pediatric to adult care. Researchers want to see if the app …

This study is testing a mobile phone app designed to help people with hepatitis D, a serious liver infection, better manage their health. The app allows patients to track key health information and communicate more easily with their doctors between visits. Researchers want to see…

This study follows 36 Italian patients with Polycythemia Vera, a chronic blood cancer, who previously responded well to the drug Ropeginterferon alfa-2b. Researchers will track these patients for several years to see if the treatment continues to control their disease safely and …

This study aims to understand why some patients with a blood cancer called essential thrombocythemia (ET) later develop a related cancer called polycythemia vera (PV). Researchers will look back at the medical records of 678 patients to identify risk factors for this change and c…

This study is testing a new, automatic screening method to find more people who have Hepatitis Delta, a severe form of liver disease. It will involve about 244 people in Bergamo, Italy, who are already known to have Hepatitis B. The main goal is to see how many of these people al…

This study aims to gather detailed information on how myelofibrosis, a rare and serious bone marrow cancer, affects patients in everyday clinical practice. It will follow over 600 patients across Europe for several years, tracking their health, treatments, and quality of life. Th…